News

• 2025.05.13 news
  Announcement of media coverages regarding the XPRIZE Healthspan, a global competition for the human longevity
• 2025.02.21 news
  Notice of a newspaper article publication regarding the start of Phase III clinical trial for malignant melanoma with a PAI-1 inhibitor RS5614
• 2025.01.31 news
  A newspaper article about our aging and longevity researches was published
• 2024.10.21 news
  Notice of a special lecture on our PAI-1 inhibitor RS5614 at the 31st Japanese Society of Transfusion Medicine and Cell Therapy
• 2024.10.10 news
  Notice regarding head office relocation
• 2024.09.09 news
  Presentation of the pharmacological action of PAI-1 inhibitor RS5614 in non-small cell lung cancer at the 2024 World Conference on Lung Cancer (WCLC) in San Diego
• 2024.09.03 news
  Notice of publication of a newspaper article in Kahoku Shimpo regarding malignant melanoma treatment drug
• 2024.06.05 news
  Notice of Publication of Article on Immune Checkpoint Inhibitory Effect of PAI-1 Inhibitor RS5614
• 2024.01.19 news
  Notice of Publication of Article Related to the Development of RS5614, a PAI-1 Inhibitor for the Treatment of Non-Small Cell Lung Cancer
• 2024.01.03 news
  Notice of Publication of Article on Results of Late Phase II Study of Novel Coronavirus Lung Injury